Microglial Hv1 proton channel promotes cuprizone-induced demyelination through oxidative damage

Junli Liu1,2, Daishi Tian2,3, Madhuvika Murugan2

  • 1Cancer center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Insights

The voltage-gated proton channel Hv1 in microglia drives oxidative damage and demyelination in a mouse model of multiple sclerosis (MS). Inhibiting Hv1 reduces damage, suggesting it as a therapeutic target for MS.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia-driven reactive oxygen species (ROS) production is implicated in multiple sclerosis (MS) pathogenesis, contributing to demyelination and tissue injury.
  • The voltage-gated proton channel Hv1 is crucial for NADPH oxidase (NOX)-dependent ROS generation and is specifically expressed in microglia.

Purpose of the Study:

  • To investigate the role of microglial Hv1 proton channels in cuprizone-induced demyelination, a mouse model mimicking MS.
  • To elucidate the mechanisms by which Hv1 influences microglial activation, ROS production, and oligodendrocyte damage.

Main Methods:

  • Utilized a cuprizone-induced demyelination mouse model.
  • Compared wild-type mice with mice lacking the Hv1 channel (Hv1(-/-)).
  • Assessed demyelination, myelin basic protein expression, oligodendrocyte counts, motor function, and ROS production.

Main Results:

  • Wild-type mice exposed to cuprizone showed significant demyelination, reduced myelin basic protein, oligodendrocyte loss, and motor deficits.
  • Hv1(-/-) mice were partially protected from demyelination and motor impairments.
  • Hv1 deficiency led to reduced ROS production, decreased microglial activation, and increased oligodendrocyte progenitor cell proliferation and mature oligodendrocyte numbers.

Conclusions:

  • The Hv1 proton channel is essential for cuprizone-induced microglial oxidative stress and subsequent demyelination in this MS model.
  • Targeting microglial Hv1 presents a potential therapeutic strategy for mitigating NOX-dependent ROS production and neuroinflammation in MS.

Related Concept Videos